Impact of therapy sequence on survival outcomes among patients with relapsed or refractory mature T and NK cell neoplasms: A global retrospective cohort study Meeting Abstract


Authors: Sorial, M. N.; Koh, M. J.; Boussi, L.; Han, J. X.; Peng, L.; Eche-Ugwu, I. J.; Duan, R.; Lei, M. M.; Miranda, E.; Chiattone, C.; Stuver, R.; Horwitz, S. M.; Turizo, M. J. F.; McCabe, S.; Merrill, M. H.; Jacobsen, E.; Kim, J. S.; Kim, Y. R.; Cho, J. Y.; Jain, H.; Sengar, M.; Eipe, T.; Shet, T.; Singh, S.; Lou, U.; Raghib, H.; Gabler, J.; Koh, M. J.; Van der Weyden, C.; Prince, M.; Hamouche, R.; Muradashvili, T.; Foss, F. M.; Gentilini, M.; Casadei, B.; Zinzani, P. L.; Okatani, T.; Yoshida, N.; Yoon, S. E.; Kim, W. S.; Panchoo, G.; Mohamed, Z.; Verburgh, E.; Alturas, J. C.; Al Mansour, M.; Ford, J.; Manni, M.; Federico, M.; O'Connor, O. A.; Cabrera, M. E.; Marchi, E.; Shen, C. Y.; Shah, D.; Jain, S.
Abstract Title: Impact of therapy sequence on survival outcomes among patients with relapsed or refractory mature T and NK cell neoplasms: A global retrospective cohort study
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 3080
Language: English
ACCESSION: WOS:001159740302189
DOI: 10.1182/blood-2023-182341
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz
  2. Robert Nicolais Stuver
    57 Stuver
  3. Leora Sarah Boussi
    9 Boussi